Pathophysiology of diabetic macular edema

International Ophthalmology Clinics

Volumn 49, Issue 2, 2009, Pages 1-11

  Singh, Ajay ^a   Stewart, Jay M ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD RETINA BARRIER; COMPLEMENT SYSTEM; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; HUMAN; KALLIKREIN KININ SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; DISEASE COURSE; HEALTH; INCIDENCE; PATHOLOGY; PREVALENCE; RETINA; RETINA MACULA EDEMA;

DIABETIC RETINOPATHY; DISEASE PROGRESSION; HUMANS; INCIDENCE; MACULAR EDEMA; PREVALENCE; RETINA; WORLD HEALTH;

EID: 67650252211     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e31819fd164     Document Type: Review

References (34)

1. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998;105:1801-1815.
2. Murray RK, Granner DK, Mayes PA, et al. The respiratory chain and oxidative phosphorylation. In: Foltin J, Ransom J, Oransky JM, eds. Harper's Illustrated Biochemistry. 26th ed. New York, NY: McGraw-Hill Companies; 2003:92-101
3. Fatt I, Shantinath K. Flow conductivity of retina and its role in retinal adhesion. Exp Eye Res. 1971;12:218-226.
4. Nagelhus EA, Veruki ML, Torp R, et al. Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Müller cells and fibrous astrocytes. J Neurosci. 1998;18:2506-2519. (Pubitemid 28141799)
5. Antcliff RJ, Hussain AA, Marshall J. Hydraulic conductivity of fixed retinal tissue after sequential excimer laser ablation: barriers limiting fluid distribution and implications for cystoidmacular edema. Arch Ophthalmol. 2001;119:539-544. (Pubitemid 32290062)
6. Bringmann A, Reichenbach A, Wiedemann P. Pathomechanisms of cystoid macular edema. Ophthalmic Res. 2004;36:241-249. Review.
7. Pannicke T, Iandiev I, Uckermann O, et al. A potassium channel-linked mechanism of glial cell swelling in the postischemic retina. Mol Cell Neurosci. 2004;26:493-502. (Pubitemid 38969947)
8. Antcliff RJ, Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol. 1999;14:223-232. Review.
9. Hainsworth DP, Katz ML, Sanders DA, et al. Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus. Comp Med. 2002;52:523-529.
10. Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 2005;7:452-464. Review. (Pubitemid 41555617)
11. Rucker HK, Wynder HJ, Thomas WE. Cellular mechanisms of CNS pericytes. Brain Res Bull. 2000;51:363-369. Review.
12. Moore J, Bagley S, Ireland G, et al. Three dimensional analysis of microaneurysms in the human diabetic retina. J Anat. 1999;194:89-100. (Pubitemid 29126698)
13. Orlidge A, D'Amore PA. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol. 1987;105:1455-1462. (Pubitemid 18029870)
14. Lindahl P, Johansson BR, Levéen P, et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997;277:242-245. (Pubitemid 27446080)
15. Kador PF, Takahashi Y, Wyman M, et al. Diabetes like proliferative retinal changes in galactose-fed dogs. Arch Ophthalmol. 1995;113:352-354.
16. Murata M, Ohta N, Fujisawa S, et al. Selective pericyte degeneration in the retinal capillaries of galactose-fed dogs results from apoptosis linked to aldose reductasecatalyzed galactitol accumulation. J Diab Complications. 2002;16:363-370.
17. Antonetti DA, Barber AJ, Khin S, et al. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes. 1998;47:1953-1959.
18. Vinores SA, Derevjanik NL, Ozaki H, et al. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Doc Ophthalmol. 1999;97:217-228. Review. (Pubitemid 30410092)
19. van Hecke MV, Dekker JM, Nijpels G, et al. Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia. 2005;48:1300-1306. (Pubitemid 41186094)
20. MacKinnon JR, Knott RM, Forrester JV. Altered L-selectin expression in lymphocytes and increased adhesion to endothelium in patients with diabetic retinopathy. Br J Ophthalmol. 2004;88:1137-1141.
21. Chibber R, Ben-Mahmud BM, Chibber S, et al. Leukocytes in diabetic retinopathy. Curr Diab Rev. 2007;3:3-14. Review.
22. Linderkamp O, Ruef P, Zilow EP, et al. Impaired deformability of erythrocytes and neutrophils in children with newly diagnosed insulin-dependent diabetes mellitus. Diabetologia. 1999;42:865-869. (Pubitemid 29325078)
23. Takamura Y, Tomomatsu T, Kubo E, et al. Role of the polyol pathway in high glucoseinduced apoptosis of retinal pericytes and proliferation of endothelial cells. Invest Ophthalmol Vis Sci. 2008;49:3216-3223.
24. Stitt AW, Li YM, Gardiner TA, et al. Advanced glycation end products (AGEs) colocalize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol. 1997;150:523-531.
25. Barile GR, Pachydaki SI, Tari SR, et al. The RAGE axis in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 2005;46:2916-2924.
26. Kaji Y, Usui T, Ishida S, et al. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Invest Ophthalmol Vis Sci. 2007;48:858-865. (Pubitemid 351260723)
27. Joussen AM, Poulaki V, Qin W, et al. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol. 2002;160:501-509. (Pubitemid 34160327)
28. Joussen AM, Poulaki V, Mitsiades N, et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J. 2002;16:438-440.
29. Kastelan S, Zjacić-Rotkvić V, Kastelan Z. Could diabetic retinopathy be an autoimmune disease? Med Hypotheses. 2007;68:1016-1018.
30. Gao BB, Clermont A, Rook S, et al. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat Med. 2007;13:181-188. (Pubitemid 46245763)
31. Wagner J, Jan Danser AH, Derkx FH, et al. Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol. 1996;80:159-163. (Pubitemid 26058551)
32. Zhang JZ, Gao L, Widness M, et al. Captopril inhibits glucose accumulation in retinal cells in diabetes. Invest Ophthalmol Vis Sci. 2003;44:4001-4005. (Pubitemid 37047975)
33. Xia P, Inoguchi T, Kern TS, et al. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes. 1994;43:1122-1129. (Pubitemid 24265474)
34. Leal EC, Manivannan A, Hosoya K, et al. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2007;48:5257-5265. (Pubitemid 351260939)